Welcome to the Miller Lab at the Medical College of Wisconsin Cancer Center. Our lab is focused on understanding the causes of drug resistance in breast cancer and the discovery of new treatment strategies.
Metabolic Response to CDK4/6 Inhibition in ER+ Breast Cancer Creates a Therapeutic Vulnerability in Drug-Tolerant Persister Cells.
Huijuan Yang, Steven Tau, Andrew D McCray, Alyssa M Roberts, Jonathan D Marotti, Kristen Muller, Yuzhou Huang, Md Al Mamun, Kazuhiro Aoki, Eugene Demidenko, Todd W Miller.
FASEB J. 2026 Apr 15;40(7):e71746. doi: 10.1096/fj.202502515RR.
Epithelial-Mesenchymal Transition is Associated with Altered Immune Composition and Cytotoxic Function in Triple-Negative Breast Cancer.
Hanxu Lu, Meisam Bagheri, Fred W Kolling, Lucas A Salas, Xiaofeng Wang, Todd W Miller, Diwakar R Pattabiraman, Brock Christensen.
bioRxiv [Preprint]. 2025 Oct 23:2025.10.22.683714. doi: 10.1101/2025.10.22.683714.
Combined Radiation and Endocrine Therapies Elicit Benefit in ER+ Breast Cancer.
Anneka L Johnson, Steven Tau, Austin M Sloop, Tianyuan Dai, Alyssa M Roberts, Patricia Muskus, Alexa Warren, Sierra A Kleist, Riley A Hampsch, Julie M Jorns, Rongxiao Zhang, Lesley A Jarvis, Todd W Miller.
Cancers (Basel). 2025 Jun 9;17(12):1921. doi: 10.3390/cancers17121921.